Holen Sie sich die Stockscreener-App
3.56
1.39%
-0.05
Handel nachbörslich:
3.70
0.14
+3.93%
Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
269.35%
12.70
|
3.439 | 0.344 | -1.781 | 5.177 |
Operating Expenses
|
3.26%
11.19
|
11.57 | 11.75 | 18.92 | 20.38 |
| Benefits Costs and Expenses |
100.00%
-
|
13.18 | 16.55 | - | - |
| Costs And Expenses |
15.09%
11.19
|
13.18 | 16.55 | 18.92 | 20.38 |
| Operating Income/Loss |
118.57%
1.51
|
-8.13 | -11.41 | -20.70 | -15.21 |
| Nonoperating Income/Loss |
18.98%
-1.306
|
-1.612 | -4.792 | -2.156 | -1.98 |
| Income/Loss From Continuing Operations Before Tax |
230.38%
12.70
|
-9.742 | -16.20 | -1.781 | -17.19 |
| Income/Loss From Continuing Operations After Tax |
102.09%
0.204
|
-9.742 | -16.20 | -22.86 | -17.19 |
|
Net Income/Loss
|
102.09%
0.204
|
-9.742 | -16.20 | -22.86 | -17.19 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
90.00%
9.4881
|
94.84 | 5.2103 | 46.81 | 46.50 |
| Diluted Average Shares |
89.99%
9.4906
|
94.84 | 5.2103 | 46.81 | 46.50 |
| Basic Earnings Per Share |
120.00%
0.02
|
-0.10 | -0.18 | -0.49 | -0.37 |
| Diluted Earnings Per Share |
120.00%
0.02
|
-0.10 | -0.18 | -0.49 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):